Real-world Study of Acalabrutinib
NCT06767891
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
200
Enrollment
OTHER
Sponsor class
Conditions
MCL
CLL
Sponsor
Ruijin Hospital
Collaborators
[object Object]